BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37547501)

  • 1. Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery.
    Ashraf Ganjooei N; Jamialahmadi T; Nematy M; Shah NZ; Jangjoo S; Emami N; Jangjoo A; Faridnia R; Alidadi M; Sathyapalan T; Sahebkar A
    Middle East J Dig Dis; 2022 Oct; 14(4):410-421. PubMed ID: 37547501
    [No Abstract]   [Full Text] [Related]  

  • 2. The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Abdalla MA; Akhlaghi S; Sathyapalan T; Sahebkar A
    Eat Weight Disord; 2022 Mar; 27(2):693-700. PubMed ID: 33999371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease.
    Guo W; Qin P; Li XN; Wu J; Lu J; Zhu WF; Diao QQ; Xu NZ; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():711956. PubMed ID: 34456869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Hospital Based Observational Study to Detect Non-Alcoholic Steatohepatitis by Acoustic Radiation Force Impulse in Individuals with Diabetes Mellitus and Metabolic Syndrome.
    Singhai A; Shaji N
    Mymensingh Med J; 2023 Jul; 32(3):847-854. PubMed ID: 37391984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery.
    Jamialahmadi T; Jangjoo A; Rezvani R; Goshayeshi L; Tasbandi A; Nooghabi MJ; Rajabzadeh F; Ghaffarzadegan K; Mishamandani ZJ; Nematy M
    Obes Surg; 2020 Jun; 30(6):2251-2258. PubMed ID: 32198617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
    Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
    Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
    BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
    Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
    Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease.
    Kim JW; Lee CH; Kim BH; Lee YS; Hwang SY; Park BN; Park YS
    Quant Imaging Med Surg; 2022 Mar; 12(3):1815-1829. PubMed ID: 35284276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    D'Ambrosio R; Campi I; Maggioni M; Perbellini R; Giammona E; Stucchi R; Borghi M; Degasperi E; De Silvestri A; Persani L; Fugazzola L; Lampertico P
    PLoS One; 2021; 16(4):e0249614. PubMed ID: 33822817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.
    Laursen TL; Hagemann CA; Wei C; Kazankov K; Thomsen KL; Knop FK; Grønbæk H
    World J Hepatol; 2019 Feb; 11(2):138-149. PubMed ID: 30820265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.
    Mendoza YP; Rodrigues SG; Delgado MG; Murgia G; Lange NF; Schropp J; Montani M; Dufour JF; Berzigotti A
    Liver Int; 2022 Jan; 42(1):102-111. PubMed ID: 34821035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.